Fulvestrant
About Fulvestrant
Fulvestrant is a prescription hormonal therapy used to treat hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer. It works by blocking and breaking down estrogen receptors on breast cancer cells, slowing or stopping the growth of cancers that depend on estrogen to grow.
This medicine is administered as an intramuscular (IM) injection by a trained healthcare professional. Treatment is usually given once every month, with an additional dose two weeks after the first injection. Your doctor may prescribe Fulvestrant alone or in combination with other targeted anticancer medicines depending on your treatment plan.
During treatment, your doctor will monitor your response through regular medical check-ups and blood tests, including liver function tests when appropriate. Common side effects include injection-site pain, hot flushes, nausea, fatigue, and joint or muscle pain. Contact your healthcare provider immediately if you develop yellowing of the skin or eyes, severe allergic reactions, unusual bleeding or bruising, severe leg swelling, chest pain, or shortness of breath.
Before starting treatment, tell your doctor if you have liver disease, bleeding disorders, low platelet counts, or are taking blood-thinning medicines. Inform your healthcare provider about all prescription medicines, over-the-counter medicines, herbal products, and dietary supplements you use before receiving this medicine.
This medicine can harm an unborn baby and should not be used during pregnancy. Women who could become pregnant should use effective contraception during treatment and for 2 years after the final dose. Breastfeeding is not recommended during treatment or for 1 year after the last dose. Older adults generally do not require dose adjustment but may need closer monitoring depending on their overall health.
Uses of Fulvestrant
Medicinal Benefits
When used as prescribed, Fulvestrant offers several important benefits in the treatment of hormone receptor-positive breast cancer.
- Blocks estrogen-driven cancer growth: Fulvestrant blocks and destroys estrogen receptors, helping prevent estrogen from stimulating the growth of breast cancer cells.
- Slows disease progression: By reducing estrogen signalling, this medicine helps slow the growth and spread of advanced breast cancer.
- Works after previous hormonal therapy: Fulvestrant remains an effective treatment option for many patients whose cancer has progressed despite previous endocrine therapies.
- Maintains quality of life: Because it specifically targets hormone receptors rather than rapidly dividing cells, many patients experience fewer systemic side effects than with traditional chemotherapy while maintaining daily activities.
Directions for Use
- Your doctor will decide the dosage and timing of Fulvestrant based on the stage of cancer and your body’s response to the treatment. Usually, it is given every two weeks for the first three doses, then once monthly.
- Fulvestrant will be administered by a doctor or nurse in a medical facility.
- Do not self-administer.
Storage
Side Effects of Fulvestrant
Common Side Effects (Usually mild):
- Pain, swelling, or redness at the injection site
- Hot flushes
- Nausea
- Fatigue or weakness
- Joint, muscle, or bone pain
- Headache
- Increased liver enzyme levels
Serious Side Effects (Consult your doctor right away):
- Yellowing of the skin or eyes, dark urine, or severe upper abdominal pain (possible liver problems)
- Severe allergic reactions, including swelling of the face, lips, tongue, or throat, hives, or difficulty breathing
- Severe pain, numbness, tingling, or weakness in the buttock or leg following the injection (possible sciatic nerve injury)
- Unusual bruising or prolonged bleeding, particularly if you are taking blood-thinning medicines
- Signs of a blood clot, such as sudden leg swelling or pain, chest pain, or sudden shortness of breath
Medicines Containing this Salt
View AllDrug Warnings
- Attend all scheduled injections: Receiving your injections on time helps maintain consistent estrogen receptor blockade and improves treatment effectiveness.
- Tell your doctor if you take blood thinners: Medicines such as warfarin or other anticoagulants may increase the risk of bleeding or bruising following the intramuscular injection.
- Report persistent injection-site pain: Inform your healthcare provider if you develop severe pain, swelling, numbness, tingling, or weakness in your buttock or leg after the injection.
- Monitor your liver function: Regular blood tests may be required during treatment, particularly if you have a history of liver disease.
- Pregnancy warning: This medicine can harm an unborn baby. Use effective contraception during treatment and for at least 2 years after your final dose if you could become pregnant. Do not breastfeed during treatment.
- Inform every healthcare provider that you are receiving hormonal therapy: This is especially important before starting new medicines or undergoing surgical procedures.
- Do not stop treatment without medical advice: Continue receiving your injections for as long as your doctor recommends, even if you feel well.
- When to seek urgent medical care: Seek immediate medical attention if you develop severe allergic reactions, yellowing of the skin or eyes, sudden chest pain, shortness of breath, or symptoms of a blood clot.
Drug Interactions
- Anticoagulants (such as warfarin): Fulvestrant should be used cautiously with blood-thinning medicines because intramuscular injections may increase the risk of bleeding or large injection-site haematomas.
- Other anticancer medicines: Fulvestrant is commonly used with targeted therapies such as CDK4/6 inhibitors. Your healthcare team will monitor you closely for side effects during combination treatment.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
cautionAvoid alcohol consumption while receiving this medicine. If you have any concerns, please discuss them with your doctor.
Pregnancy
unsafeFulvestrant is not recommended for use during pregnancy as it may harm the unborn baby. You are advised to use effective contraception while being treated with Fulvestrant and for two years after your last dose.
Breast Feeding
unsafeFulvestrant is contraindicated for use during lactation, or you are recommended to avoid breastfeeding while on treatment with Fulvestrant.
Driving
safe if prescribedFulvestrant usually does not affect your ability to drive or operate machinery. However, avoid driving or operating machinery if you feel tired or weak after receiving Fulvestrant.
Liver
cautionFulvestrant is not recommended for patients with severe liver problems. Therefore, if you have liver problems, inform your doctor before receiving Fulvestrant.
Kidney
cautionIf you have kidney problems, inform your doctor before receiving Fulvestrant.
Children
unsafeFulvestrant is not recommended for children and adolescents below 18 years of age.
Habit Forming
Diet & Lifestyle Advise
- Eat a balanced diet: Include plenty of fruits, vegetables, whole grains, and lean protein to help maintain your strength during cancer treatment.
- Support bone health: Your doctor may recommend adequate calcium and vitamin D intake, along with weight-bearing exercise, especially if you are at risk of osteoporosis.
- Stay physically active: Gentle activities such as walking or stretching may help reduce joint stiffness, improve energy levels, and maintain muscle strength.
- Limit alcohol intake: Alcohol may increase the risk of liver problems. Discuss alcohol consumption with your doctor during treatment.
- Maintain a healthy weight: Achieving and maintaining a healthy body weight may support your overall health during breast cancer treatment.
- Attend regular follow-up appointments: Routine medical reviews help monitor your response to treatment and detect side effects early.
Patients Concern
Disease/Condition Glossary
Breast cancer: It is a type of cancer that develops in the breast when the cells grow abnormally. The tumor cells invade other healthy breast cells and can travel to lymph nodes, a primary pathway for the cancer cells to move to other parts of the body. Symptoms include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size, or appearance of the breast, peeling, flaking or scaling of the skin, and a lump or swelling under the arm.
FAQs
Fulvestrant is used to treat Breast cancer in postmenopausal women.
Fulvestrant contains Fulvestrant which works by inhibiting some of the actions of estrogen (female sex hormone) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.
Fulvestrant is not recommended for patients with severe liver problems. Therefore, if you have any liver problems, inform your doctor before receiving Fulvestrant.
Fulvestrant may cause weakness or tiredness as a common side effect. However, if weakness persists or worsens, please consult your doctor.
Fulvestrant contains Fulvestrant, which belongs to a class of medications called estrogen receptor antagonists. It helps to slow or stop the growth of specific breast tumours that depend on estrogen (a female sex hormone) to grow.
Fulvestrant is administered as a liquid injection into a muscle in the buttocks by a doctor in a medical setting. It is typically injected slowly over 1 to 2 minutes. For the first three doses, you will receive an injection every two weeks (on days 1, 15, and 29). After that, it is usually given once a month. Your doctor will determine the exact schedule based on your condition and how you respond to the medication. The injection will be given as two separate shots (one in each buttock). Please do not self-administer it.
Fulvestrant may cause common side effects, such as injection site reactions like pain and inflammation, weakness, nausea, tiredness, headache, or joint and musculoskeletal pain in some individuals. Most of these side effects of Fulvestrant do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.
Fulvestrant is given as an injection directly into the muscle of your buttocks. It is administered slowly by a trained healthcare professional in a clinic or doctor's office. Talk to your doctor if you have questions about the injection process.
Fulvestrant is specifically approved for women who are postmenopausal. If you are premenopausal, your doctor may only consider this treatment if it is combined with other medications that suppress ovarian function. Talk to your doctor to see if this treatment is right for you.
While hair thinning can sometimes occur with hormone therapies, complete hair loss is not a common side effect of Fulvestrant. If you are concerned about hair thinning, talk to your doctor or pharmacist for supportive care options.
Because Fulvestrant lowers the effect of estrogen in your body, it can potentially affect your bone density over time. Your doctor may recommend regular bone density scans or suggest calcium and Vitamin D supplements to help protect your bones. Talk to your doctor about your bone health.
No, Fulvestrant is not chemotherapy. It is a hormone therapy (specifically, an estrogen receptor downregulator) that selectively targets hormone-sensitive cancer cells, which generally results in a different side effect profile than traditional chemotherapy. Talk to your doctor for more details.
Most people can drive safely after receiving their injection, as it does not typically cause drowsiness. However, if you feel dizzy, weak, or experience pain at the injection site that affects your movement, avoid driving and talk to your doctor.
It is very important to get your injections on time to keep the treatment working. If you miss an appointment, contact your healthcare provider right away to schedule a make-up injection. Talk to your doctor or pharmacist if you need help tracking your schedule.
Author Details
